Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2018 Aug;11(8):1084–1093. doi: 10.1016/j.jcmg.2018.06.005

Figure-2. Rate of Cardiac Monitoring and Recommended Cardiac Monitoring by Age Group.

Figure-2.

The percentage of cardiac monitoring at baseline (before trastuzumab treatment), at follow-up, and the overall rate of recommended cardiac monitoring by age group in trastuzumab-treated breast cancer patients (n=4325).